Jasmina Esterlechner

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

A. Kerstan, Philipp Schrüfer, M. Goebeler, 2020, Cytotherapy.

In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials

A. Kerstan, D. Orgill, K. Scharffetter-Kochanek, 2019, Cytotherapy.

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

A. Kerstan, M. Jünger, G. Daeschlein, 2022, Stem Cell Research & Therapy.

Clinical trial of ABCB5 + mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

J. Tolar, C. Ebens, A. Hovnanian, 2021 .

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

A. Kerstan, M. Jünger, G. Daeschlein, 2021, JID innovations.

Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues

M. Frank, E. Niebergall-Roth, M. Kluth, 2023, Cells.